SHOULD WE KEEP USING RIBAVIRIN TO TREAT HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION? RESULTS FROM THE CO23 ANRS CUPILT STUDY

  P. Houssel-Debry ^{1, 2} AuthorId : 1175941
Author

  C. Duvoux ³ AuthorId : 770180
Author

  A. Coilly ⁴ AuthorId : 1175935
Author

  C. Fougerou-Leurent ^{1, 2} AuthorId : 1175936
Author

  C. Jezequel ² AuthorId : 384563
Author

  V. de Ledinghen AuthorId : 1175955
Author

  S. Radenne ⁵ AuthorId : 1175938
Author

  N. Kamar ⁶ AuthorId : 512788
Author

  V. Leroy AuthorId : 208541
Author

  V. Di Martino ⁷ AuthorId : 475064
Author

  L. d'Alteroche ⁸ AuthorId : 351050
Author

  V. Canva ⁹ AuthorId : 314959
Author

  F. Conti ¹⁰ AuthorId : 1175943
Author

  J. Dumortier ⁵ AuthorId : 341310
Author

  H. Montialoux AuthorId : 490184
Author

  P. Lebray ¹⁰ AuthorId : 1175957
Author

  D. Botta-Fridlund ¹¹ AuthorId : 1175934
Author

  R. Anty AuthorId : 1175959
Author

  C. Moreno ¹² AuthorId : 102658
Author

  C. Silvain ^{13, 14} AuthorId : 421770
Author

  C. Besch ¹⁵ AuthorId : 1175958
Author

  P. Perré AuthorId : 557212
Author

  F. Durand AuthorId : 1547189
Author

  A. Abergel ¹⁶ AuthorId : 61298
Author

  F. Habersetzer AuthorId : 1176038
Author

  M. Debette-Gratien AuthorId : 1408455
Author

  A. Rohel ¹⁷ AuthorId : 1175944
Author

  A. Diallo ¹⁷ AuthorId : 119006
Author

  E. Rossignol ¹ AuthorId : 1415976
Author

  A. Veislinger ¹ AuthorId : 1176084
Author

  H. Danjou ¹ AuthorId : 1175937
Author

  J. -C. Duclos-Vallee AuthorId : 1175960
Author

  G. -P. Pageaux AuthorId : 1176057
Author